If you think you’re the right fit for a GLP-1 agonist medication, we don’t recommend seeking out a proclaimed “natural” solution. Alternatively, talk to a health professional about your options.

For decades, researchers from all obesity-related disciplines have been observing the escalating prevalence of people living ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

BOULDER, CO / ACCESSWIRE / November 14, 2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Core focus on obesity includes exploratory co-administration BMT-801 study and two novel development drug candidatesPhase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Natural body mass homeostasis is best achieved by eating a diet rich in plant-derived fibre, and low in saturated fats and highly processed carbohydrates.